Insider Transactions in Q2 2022 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2022
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
460
-0.16%
|
$1,840
$4.02 P/Share
|
|
Jun 29
2022
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,376
-0.25%
|
$5,504
$4.02 P/Share
|
|
May 24
2022
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,471
-0.26%
|
$4,413
$3.79 P/Share
|
|
May 24
2022
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
492
-0.17%
|
$1,476
$3.79 P/Share
|
|
Apr 27
2022
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,622
-0.29%
|
$6,488
$4.72 P/Share
|
|
Apr 27
2022
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
541
-0.19%
|
$2,164
$4.72 P/Share
|
|
Apr 19
2022
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,392
-0.71%
|
$5,568
$4.98 P/Share
|